Drug
Tivozanib And Capecitabine
Tivozanib And Capecitabine: highest development phase Phase 1, developed by Aveo Pharmaceuticals. 1 trial record tracked on RxWires.
- Highest phase
- Phase 1
- Developer
- Aveo Pharmaceuticals
Trials
| Drug | Phase | Indication |
|---|---|---|
| tivozanib (AV-951) and capecitabine (Xeloda®) NCT01306630 | Phase 1 | Advanced Solid Tumors |
Latest
No recent events.
Follow Tivozanib And Capecitabine on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.